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Abstract
Background: Systemic bacterial infections often result in enduring cognitive impairment and are a risk factor for
dementia. There are currently no effective treatments for infection-induced cognitive impairment. Previous studies
have shown that intermittent fasting (IF) can increase the resistance of neurons to injury and disease by stimulating
adaptive cellular stress responses. However, the impact of IF on the cognitive sequelae of systemic and brain
inflammation is unknown.
Methods: Rats on IF for 30 days received 1 mg/kg of lipopolysaccharide (LPS) or saline intravenously. Half of the
rats were subjected to behavioral tests and the other half were euthanized two hours after LPS administration and
the hippocampus was dissected and frozen for analyses.
Results: Here, we report that IF ameliorates cognitive deficits in a rat model of sepsis by a mechanism involving
NF-κB activation, suppression of the expression of pro-inflammatory cytokines, and enhancement of neurotrophic
support. Treatment of rats with LPS resulted in deficits in cognitive performance in the Barnes maze and inhibitory
avoidance tests, without changing locomotor activity, that were ameliorated in rats that had been maintained on
the IF diet. IF also resulted in reduced levels of mRNAs encoding the LPS receptor TLR4 and inducible nitric oxide
synthase (iNOS) in the hippocampus. Moreover, IF prevented LPS-induced elevation of IL-1α, IL-1β and TNF-α levels,
and prevented the LPS-induced reduction of BDNF levels in the hippocampus. IF also significantly attenuated
LPS-induced elevations of serum IL-1β, IFN-γ, RANTES, TNF-α and IL-6 levels.
Conclusions: Taken together, our results suggest that IF induces adaptive responses in the brain and periphery that
can suppress inflammation and preserve cognitive function in an animal model of systemic bacterial infection.
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Introduction
Systemic inflammation/sepsis is a risk factor for cogni-
tive impairment and dementia [1]. The elderly are vul-
nerable to the adverse effects of infections on cognitive
function, and the aging process itself is associated with
increased neuroinflammatory processes involving micro-
glial activation and production of pro-inflammatory cy-
tokines [2,3]. Inflammation also occurs in association
with the pathological changes in the brains of patients
with Alzheimer’s disease (AD) and ischemic stroke [4].
However, clinical trials of anti-inflammatory therapies for
AD, including NSAIDs, TNF inhibitors and intravenous
immunoglobulin [5,6], have not been encouraging [7-10].
NF-κB, the activity of which is attributed to the Rel/
NF-κB family proteins forming homo- and heterodimers
through the combination of the subunits p65 (or RELA),
p50, p52, cREL and RELB, can be activated by lipopoly-
saccharide (LPS), cytokines such as TNF-α and IL-1β,
and reactive oxygen species [11,12]. NF-κB, which is
constitutively expressed in the cytoplasm, is inhibited by
a family of molecules termed inhibitor κB (IκBs). IκB
binds NF-κB and masks its nuclear localization signal,
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thus retaining it in the cytoplasm [13]. Inducers of NF-
κB act by intracellular signaling pathways that activate
the IκB kinases (IKKs), which phosphorylate two specific
N-terminal serines of IκBα, resulting in IκBα polyubiqui-
tination and degradation in the 26S protease [14]. When
IκB is degraded, NF-κB migrates to the nucleus, modu-
lating the transcription of several genes associated with
neurodegenerative or neuroprotective actions [15,16].
Bacterial infections activate innate immune signaling
pathways involving toll-like receptor 4 (TLR4) and the
transcription factor NF-κB in microglia and macrophages,
which induces the expression of pro-inflammatory cyto-
kines and the production of nitric oxide [17]. These path-
ways play critical roles in the killing and degradation of
the bacteria by immune cells, but can also adversely affect
neurons. Studies of TLR4-deficient mice suggest that
TLR4 signaling has a negative impact on hippocampus-
dependent cognitive function [18]. Data further suggest
that TLR4 activation contributes to the degeneration of
neurons in experimental models of AD [19,20] and stroke
[21]. Lipopolysaccharide (LPS) is a major bacterial TLR4
ligand that activates the innate immune response to infec-
tion, and administration of LPS can cause cognitive im-
pairment in animal models by mechanisms involving
expression of pro-inflammatory cytokines and inhibition
of neurotrophic factor production [22-26]. It is known that
pro-inflammatory mediators disrupt hippocampal neur-
onal functions, including long-term potentiation and
working memory consolidation [27,28]. Cytokines such as
TNF-α, IL-1β and IL-6 are involved in hippocampal long-
term potentiation and dendritic branching, which are pro-
cesses involved in memory formation and maintenance
[29]. In addition, it has already been shown that systemic
administration of TNF-α reduces cell proliferation in the
hippocampus, whereas no effect is observed with single
doses of IL-1β and IL-6 [30].
IF can improve cognitive function in mouse models rele-
vant to AD [31,32] and in old rats [33]. Also, IF reduces
brain damage, increases levels of neurotrophic factors, and
reduces markers of inflammation in a mouse model of
focal ischemic stroke [34]. Here, we report that IF amelio-
rates cognitive deficits in a rat model of systemic bacterial
infection, by a mechanism involving suppression of neuro-
inflammation and maintenance of neurotrophic support.
Our findings suggest a potential for application of IF for
the prevention and treatment of the cognitive deficits
resulting from systemic inflammation.
Material and methods
Animals
Adult 12-week-old male Wistar rats were kept under a
12-hour light/12-hour dark cycle and allowed free access
to water. All treatments were administered between 9:00
and 10:00 am. Rats were randomly assigned to a normal
feeding group and an alternate-day fasting diet (IF). Rats
on the IF diet were deprived of food for 24 hours every
other day for 30 days. On the 31st day, after being given
ad libitum access to food for 24 hours to avoid the
effects of acute fasting, each animal received 1 mg/kg of
LPS (O111:B4) (Sigma-Aldrich, St Louis, MO, USA) or
saline intravenously [35]. Thus, four groups were used:
saline (Control), LPS treatment (LPS), IF with saline (IF)
and IF with LPS treatment (IF + LPS). The LPS challenge
was performed approximately three hours after lights on
(ranging from 09:00 am to 10:00 am). Half of the rats
were subjected to behavioral tests, and the other half
were euthanized two hours after LPS administration [35]
and the hippocampus was dissected and frozen for ana-
lyses, according to the timelines shown in Figure 1. This
research was approved by the Biomedical College of
Animal Experimentation (COBEA). All procedures were
also approved by the Ethical Committee for Animal Re-
search (CEEA) of the Biomedical Sciences Institute of
the University of São Paulo.
Locomotor activity test
Spontaneous locomotor activity was measured using an
electronic animal activity meter (model 7430, Ugo Basile,
Comerio, Italy). The apparatus consisted of a transparent
acrylic cage (35 cm × 23 cm × 20 cm) with a set of hori-
zontal sensors to register locomotor activity and a set of
vertical sensors to register rearing activity. Rats were
placed into the center of cage and allowed to explore the
apparatus for five minutes while the horizontal (locomo-
tion) and vertical (rearing) movements were captured.
Thereafter, rats were returned to their home cages. The
open field was cleaned with 5% ethyl alcohol and
allowed to dry between tests.
Rotarod
Motor performance was tested using the ENV-577 M
Rotarod system (Med Associates, Georgia, VT, USA).
The time spent on the rotating rod was measured for
each animal during 300-second trials. The speed of rod
rotation was increased progressively from 3 to 30 rpm
during the 300-second period. This test consisted of four
consecutive days of testing sessions with two trials per
day. The Rotarod system was cleaned with 5% ethyl alco-
hol between tests.
Barnes maze
Spatial learning ability was examined in the Barnes maze
using methods described previously [36]. The Barnes
maze apparatus is an opaque disc 100 cm in diameter el-
evated 1 m above the floor by a tripod. Twenty holes,
8 cm in diameter, are located 9.5 cm from the perimeter,
and a black escape box is placed under one of the holes.
Distinct spatial cues are located all around the maze and
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are kept constant throughout the study. A fluorescent
lamp (21 W) was placed above the center of the arena.
A naive set of previously untested animals was posi-
tioned under an acrylic dome in the middle of the maze
for one minute. Once the dome was lifted, the animal
was able to orient to spatial cues and find the hole with
the hidden burrow. The session ended when the rat en-
tered the escape burrow or after five minutes had
elapsed. If the rat did not enter the burrow by itself, it
was gently guided and allowed to remain there for one
minute before being returned to its home cage. This test
consisted of one day of habituation session and five con-
secutive days of testing sessions with two trials per day.
The location of the burrow was the same for each indi-
vidual rat, but position was changed among rats in a
group. The maze was cleaned with 5% ethyl alcohol to
remove any odor trails. Rats are expected to reduce their
latency to find the burrow, as a measure of spatial mem-
ory. Because the Barnes maze lacks strong reinforcement
stimuli, rats may lack motivation and occasionally ex-
plore the maze after finding the target hole without en-
tering. To rectify this confounding factor, we used the
primary latency, which is the time elapsed to the first
encounter of the escape burrow.
Inhibitory avoidance
The inhibitory avoidance apparatus (Ugo Basile, Comerio,
Italy) consisted of two acrylic compartments of the same
size, one illuminated and the other dark, separated by an
automatic door. The floor of both chambers was made of
stainless steel rods and the floor of the dark chamber can
be electrified. On the training session, animals were placed
individually in the lighted compartment and the door was
opened. Once the animal entered the dark compartment,
the door was closed and an electric foot-shock (0.5 mA,
2 seconds in duration) was delivered through the grid
floor. The animal was removed from the dark compart-
ment and returned to its home cage immediately after re-
ceiving this shock. Twenty-four hours later the animals
were subjected to the test session. Animals that failed to
enter the dark compartment in 5 minutes were removed
from the apparatus and assigned a ceiling score of 300 sec-
onds. Long-term memory was assigned as the longer the
animal stayed in the light chamber. The training session
was performed on the day after the end of the Barnes
maze test.
Nuclear extracts
Nuclear extracts of each hippocampus were prepared as
previously described [37]. Briefly, hippocampal struc-
tures were homogenized using a Dounce homogenizer
in cold PBS supplemented with, 0.5 mM PMSF, 2.5 μg/
ml leupeptin and 2.5 μg/ml antipain, and centrifuged at
4°C for 30 seconds at 12,000 × g. The supernatants (cyto-
plasmic extract) were reserved for immunoblot, and the
pellets were resuspended in lysis buffer (10 mM HEPES
Figure 1 Design of experiments to determine the effects of intermittent fasting (IF) on cognitive function and hippocampal
neuroinflammation. (A) For the biochemical experiments, rats were subjected to IF or ad libitum Control diets for 30 days. To determine
whether IF modulated the inflammatory response to a subsequent challenge, rats were injected intravenously with either 1 mg/kg
lipopolysaccharide (LPS) or saline on day 31, and 2 hours later brain tissue and serum samples were collected for subsequent analysis.
(B) For the behavioral experiments, rats were subjected to the habituation session of the Barnes maze and were immediately injected
intravenously with either 1 mg/kg LPS or saline on day 31. Barnes maze testing sessions and inhibitory avoidance tests were performed on days
32 to 36 and 37 to 38, respectively. Locomotor activity test was performed 24 hours after LPS administration and rotarod tests were performed
on days 32 to 35.
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pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.1 mM EDTA,
0.5 mM PMSF, 2.5 μg/ml leupeptin, and 2.5 μg/ml
antipain) and incubated on ice for 10 minutes. After
addition of NP-40 (10%), samples were vigorously mixed
and centrifuged for 30 seconds at 12,000 × g. Super-
natant was discarded, and the pellet was resuspended in
extraction buffer (20 mM HEPES pH 7.9, 25% glycerol,
1.5 mM MgCl2, 300 mM NaCl, 0.25 mM EDTA,
0.5 mM PMSF, 2.5 μg/ml leupeptin, 2.5 μg/ml antipain),
incubated 20 minutes on ice, and centrifuged for 20 mi-
nutes at 12,000 × g at 4°C. The resulting supernatants
containing nuclear proteins were stored at −80°C. Pro-
tein concentration was determined using the Bio-Rad
(Richmond, CA, USA) colorimetric assay [38].
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) for NF-κB was
performed by using the gel shift assay kit from Promega
(Madison, WI, USA), as described previously [37]. 32P-NF-
κB double-stranded consensus oligonucleotide probe (5’-
AGTTGAGGGGACTTTCCCAGGC-3’; 25,000 cpm) and
nuclear extracts (15 μg) were used. DNA-protein com-
plexes were separated by electrophoresis through a 6%
non-denaturing acrylamide:bis-acrylamide (37.5:1) gel in
0.53 Tris-borate/EDTA (TBE) for two hours at 150 V. Gels
were vacuum dried and analyzed by autoradiography. For
competition experiments, NF-κB and transcription ini-
tiation factor II (TFIID; 5’-GCAGAGCATATAAGGT-
GAGGTAGGA-3’) unlabeled double-stranded consensus
oligonucleotide was included in 20-fold molar excess over
the amount of 32P-NF-κB probe to detect specific and non-
specific DNA-protein interactions, respectively. Unlabeled
oligonucleotides were added to the reaction mixture 20 mi-
nutes before the radioactive probe. Supershift assay incu-
bations, using antibodies against different NF-κB subunits
(p50, p52, cREL and RELA, 1:20 dilution), were also con-
ducted according to the protocol of the manufacturer
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) before
the incubation of nuclear extracts with the labeled oligo-
nucleotide. Autoradiographs were visualized with a photo-
documentation system DP-001-FDC (Vilber Lourmat,
Marne la Vallée, France) and quantified in NIH ImageJ
software (Bethesda, MD, USA). Several exposure times
were analyzed to ensure the linearity of the band
intensities.
Immunoblotting
Electrophoresis was performed using a 10% polyacryl-
amide gel and the Bio-Rad mini-Protean III apparatus
(Bio-Rad, Richmond, CA, USA). In brief, the proteins
present in the hippocampus cytosolic (15 μg) and nuclear
fractions (10 μg) were size separated in 10% SDS-PAGE
(90 V). The proteins were blotted onto a nitrocellulose
membrane (Bio-Rad, Richmond, CA, USA) and incubated
with specific antibodies against RELA (sc-372; Santa Cruz
Biotechnology, Santa Cruz, CA, USA). The Ponceau
method of immunoblotting was used to ensure equal pro-
tein loading [39]. Proteins recognized by antibodies were
revealed by the enhanced chemiluminescence (ECL) tech-
nique, following the instructions of the manufacturer
(Amersham, Buckinghamshire, England). The membranes
were exposed to x-ray film. To quantify the immunoblots,
we used the NIH ImageJ software Bethesda, MA, USA).
Several exposure times were analyzed to ensure the linear-
ity of the band intensities. β-ACTIN antibody (sc-1616;
Santa Cruz Biotechnology, Santa Cruz, CA, USA) was
used as an internal control for the experiments. Results
were expressed in relation to the intensity of β-ACTIN
band.
Multiplex analysis of cytokines and chemokines
Concentrations of IL-1α, IL-1β, TNF-α, IL-6, IFN-γ
and RANTES were simultaneously measured in 25 μL of
serum and extracts from homogenized hippocampus using
a Milliplex MAP kit Rat Cytokine/Chemokine Magnetic
Bead Panel (Millipore, Billerica, MA, USA) by following
instructions of the manufacturer. Briefly, hippocampal tis-
sue was homogenized in a buffer containing 150 mM
NaCl, 0.05% Tween-20, 1 mM PMSF, 2.5 ug/ml antipain,
2.5 ug/ml leupeptin and 20 mM Tris-HCl (pH 7.5), and
protein concentration was measured in each sample. Anti-
body immobilized beads were detected on a Luminex 100
xMAP technology machine (Austin, TX, USA). Standard
curves were generated for each cytokine/chemokine using
standards included in the kit diluted in kit matrix for
serum samples and lysis buffer for tissue samples. The me-
dian fluorescence intensity for each analyte was calculated
using a five-point logistic parameter curve, and normalized
to the amount of protein in each sample. Concentrations
of serum IL-1α and TNF-α, and tissue IL-1β and IL-10,
were consistently below the level of detection of the assay.
Therefore, we measured IL-10 and IL-1β levels in hippo-
campal extracts and TNF-α in serum by a conventional
ELISA kit.
ELISA
Hippocampal levels of IL-1β and IL-10, and serum levels
of TNF-α were measured by ELISA using eBioscience
(San Diego, CA, USA) kits, and hippocampal levels of
brain-derived fa (BDNF) were measured using a Pro-
mega ELISA kit (Madison, WI, USA). To measure TNF-
α, IL-1β and IL-10 levels, serum was isolated within
30 minutes after blood (5 ml) collection by centrifuging
at 3,000 × g for 10 minutes, and cytosolic hippocampal
extract was isolated by homogenizing hippocampi struc-
tures using a Dounce homogenizer in cold PBS supple-
mented with 0.5 mM PMSF, 2.5 μg/ml leupeptin and
2.5 μg/ml antipain, and centrifuging at 4°C for
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30 seconds at 12,000 × g. To measure BDNF levels,
hippocampus samples were prepared according to the
instructions of the manufacturer. Briefly, the tissue was
homogenized in lysis buffer (137 mM NaCl, 20 mM Tris
HCl pH 8, 1% NP40, 10% glycerol, 0.5 mM PMSF,
2.5 μg/ml leupeptin, and 2.5 μg/ml antipain), then cen-
trifuged for 2 minutes at 12,000 × g. The supernatants
were stored at −80°C.
RNA extraction and Real-Time RT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen,
Carlsbad, CA, USA) according to the instructions of the
manufacturer. To avoid genomic DNA contamination,
total RNA was treated with deoxyribonuclease I (DNase I)
and RNase-free enzyme (Fermentas, Vilnius, Lithuania) be-
fore RT reactions. Quantification and purity of RNA sam-
ples were performed by measuring absorbance at 260 nm
and 280 nm on a spectrophotometer. A 260/280 nm ab-
sorbance ratio ranging between 1.7 and 2.1 was considered
an acceptable purity. cDNA was synthesized with reverse
transcriptase from Promega (Madison, WI, USA) using
random primers and following instructions of the manu-
facturer. Real-time RT-PCR analysis was performed with
the 7500 Fast Real-Time PCR System (Applied Biosystems,
Foster City, CA, USA). The PCR thermal cycling condi-
tions were as follows: 95°C for 4 minutes, 40 cycles of 94°C
for 45 seconds, 60°C for 45 seconds, 72°C for 45 seconds,
and 80°C for 10 seconds (during which the fluorescence
was measured), and final extension at 72°C for 7 minutes.
Each reaction (performed in duplicate) included 3 μl of di-
luted (1:10) cDNA, 6 μl of 2x GoTaq qPCR Master Mix
(Promega, Madison, WI, USA), primers (final concentra-
tion of 150 nM each), and sterile bi-distilled water up to a
final volume of 12 μl. Amplicons that span over two or
more exons were selected, whenever possible, to distin-
guish between amplification of mature mRNA from that of
genomic DNA. Relative mRNA levels were calculated from
cycle threshold values (Ct) using the REST method [40].
Hprt mRNA (hypoxanthine-guanine phosphoribosyltrans-
ferase) was used as an internal control for each individual
sample. The mRNAs analyzed in this study were iNos and
Tlr4 (see Table 1 for primers).
Statistical analysis
Behavioral data of Barnes maze were represented as
means ± SEM and analyzed using two-way ANOVA
(treatment × trial time) with repeated measures (trial days)
followed by Bonferroni post hoc test. In the inhibitory
avoidance task, the heteroscedasticity of data and the use
of the 300-second ceiling in test sessions required the use
of nonparametric statistics. In this way, data were repre-
sented as medians and interquartile range and analyzed
using Wilcoxon signed rank test (paired and non-
parametric t-test). In order to verify the difference between
groups, Kruskal-Wallis analysis of variance followed by
Dunn’s multiple comparison test was performed. Data
from mRNA analysis were analyzed by the pairwise fixed
reallocation randomization test [40] using the relative
expression software tool (REST) that incorporates the
amplification efficiencies of the target and reference
(normalization) genes to correct for differences between
the two assays. All other data were analyzed using a one-
way ANOVA followed by Newman-Keuls post hoc com-
parison of means (GraphPad Prism 5 software package).
All results are expressed as mean ± SEM and P values <
0.05 were considered to reflect a statistically significant
difference.
Results
Intermittent fasting ameliorates memory deficits caused
by experimental systemic inflammation
The designs of experiments for tissue collection and be-
havioral testing are shown in Figure 1. Rats were main-
tained on either ad libitum (Control) or IF diets for
30 days and were then administered either vehicle (sa-
line) or LPS intravenously. The animals of both groups
were weighed before and after IF. The results showed
that IF rats had increased body mass after 30 days of diet
(Δ = 26.1 ± 3.0 g) but this increase was lower than that of
the Control group (Δ = 57.1 ± 3.0 g) (*P < 0.05, Student’s
t-test). Therefore, IF animals did gain body weight dur-
ing the 30 days period, suggesting that IF did not inter-
fere in the development of the animal. Such findings
suggest that the animals did not consume twice their
daily food intake on the ad libitum feeding day, which
resulted in a reduced body weight gain.
In the Barnes maze test, all rats were able to learn the
location of the escape burrow, as latency to find the escape
box decreased across the five blocks of daily observation
in all groups (F(4,194) = 20.31, P < 0.001 - Figure 2A). More-
over, treatment of animals with IF produced a significant
difference in their performance in the maze (F(3,194) = 4.43,
P < 0.01). Bonferroni post-test analysis indicated signifi-
cantly shorter latencies for IF and IF + LPS groups when
compared to animals injected with LPS (P < 0.001) at trial
one. As all animals experienced a previous day of habitu-
ation, these data suggest that IF increased their capacity to
Table 1 Primer sequences used in the real time RT-PCR
Gene Sequence
iNos [GenBank:
MN_0126113]
Forward 5′ AAAATGGTTTCCCCCAGTTC 3′
Reverse 5′ GTCGATGGAGTCACATGCAG 3′
Tlr-4 [GenBank:
MN_019178.1]
Forward 5′ GGATGATGCCTCTCTTGCAT 3′
Reverse 5′ TGATCCATGCATTGGTAGGTAA 3′
Hprt [GenBank:
MN_012583.2]
Forward 5′ CTCATGGACTGATTATGGACAG 3′
Reverse 5′ GCAGGTCAGCAAAGAACTTATA 3′
Vasconcelos et al. Journal of Neuroinflammation 2014, 11:85 Page 5 of 14
http://www.jneuroinflammation.com/content/11/1/85
perform the learning and memory task in the presence of
the inflammatory insult. In addition, LPS treated animals
did not acquire the information (impaired learning) and,
because of this, in the first evaluation day, they had a
worse performance. However, IF + LPS animals, submitted
to the same protocol, showed better performance in the
first evaluation day, suggesting that IF was effective in pro-
tecting against LPS-induced learning impairment.
In the inhibitory avoidance test, no significant differ-
ences were detected between groups during the training
session (Figure 2B). Results of long-term memory in the
test session 24 hours after the training session showed a
statistically significant difference in performance between
groups. Significantly greater latencies in test sessions were
observed in Control group (87.4 sec (11.7/300.0 seconds),
n = 8, P < 0.05), IF group (85.6 sec (15.3/298.0 seconds),
n = 10, P < 0.01), and IF + LPS group (183.1 sec (82.1/
300.0 seconds), n = 9, P < 0.001) when compared to the re-
spective latencies in training session, indicating that these
animals learned and memorized the task. Concerning the
LPS group, there was no significant difference between
the test session (38.6 sec (4.7/75.0 seconds), n = 9) and
Figure 2 Intermittent fasting (IF) prevents lipopolysaccharide (LPS)-induced memory impairment in the Barnes maze and inhibitory
avoidance task. (A) Barnes maze test results (***P < 0.001 versus IF and IF + LPS groups). Data are represented as the escape latency (time in
seconds that the rat takes to find the correct hole containing the burrow). (B) Inhibitory avoidance test results (*P < 0.05 IF test session versus its
training session; **P < 0.01 Control test session versus its training session; ***P < 0.001 IF + LPS test session versus its training session; #P < 0.05
IF + LPS versus LPS test sessions). Both tests showed that IF attenuated memory impairment elicited by LPS challenge. (C) Beginning 24 hours
after LPS injection, mice were tested daily for motor performance on a rotarod. The latency to fall during the testing period (four days) are
shown. (D, E) Results of the analysis of spontaneous locomotor activity in the electronic animal activity meter showing the total locomotion (D)
and total rearing (E) 24 hours after LPS administration. N = 8 to 10 for each experimental group.
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training session latency (LPS Control group = 20.7 (5.6/
36.9 seconds), n = 9), indicating that this group did not
learn the task. These findings confirmed previous data
reporting the long-lasting effects induced by LPS in animal
brains [25,41]. In addition, they showed that IF ameliorates
the long-term memory consolidation deficit induced by
LPS.
Although the comparable performances during the
learning phase argued against any interference due to
LPS-induced motor function impairment, change in motor
Figure 3 Lipopolysaccharide LPS) treatment and intermittent fasting (IF) increase the NF-κB nuclear translocation and binding activity.
Electrophoretic mobility shift assay (EMSA) and Western blot were performed using nuclear extract (10 μg) from rat hippocampus. (A) Western
blot results using antibodies to RELA and β-ACTIN showed that IF and LPS treatment with or without IF increased the nuclear translocation of
RELA. (B) EMSA showed that LPS treatment increased the NF-κB binding activity in rats submitted or not to IF protocol. IF by itself also increased
NF-κB binging activity. Competition and supershift assays of NF-κB activation by LPS treatment (C), IF (D) and IF with LPS treatment (E) were
carried out. Competition studies were performed using the nuclear extract in the absence or presence of unlabeled specific (NF-κB consensus
sequence, 20-fold molar excess) or nonspecific (TFIID consensus sequence, 20-fold molar excess) oligonucleotide, as indicated. Supershift assays
were performed with the same nuclear extract incubated in the absence or presence of antibodies (1:20 dilution) against subunits p50, RELA, and
cREL as indicated. Antibodies were added 20 minutes prior to addition of the radiolabeled NF-κB consensus oligonucleotide. The positions of
specific NF-κB/DNA and non-specific (NS) binding complexes are indicated. *P < 0.05 versus Control; #P < 0.05 versus IF. N = 5 for each
experimental group.
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skills was evaluated by using electronic animal activity
meter and rotarod apparatus. Results showed no signifi-
cant difference in the locomotor performance (locomotion
and rearing) at 24 hours of LPS treatment (LPS and IF +
LPS groups) when compared to Control and IF groups
(Figure 2D and E). Similarly, performances of LPS-treated
groups were indistinguishable from Control and IF groups
regarding the latency to fall from a rotating rod (Figure 2C).
Collectively, our results suggest that LPS causes cognitive
impairment, specifically a deficit in long-term memory re-
tention, which can be ameliorated by IF pretreatment.
Intermittent fasting modulates NF-κB transcription factor
Next, we investigated whether the IF could modulate the
activities of NF-κB with or without exposure to LPS. To
evaluate the nuclear translocation of NF-κB, we examined
nuclear protein levels by Western blot using RELA spe-
cific polyclonal antibody. Figure 3A shows that nuclear
translocation of NF-κB was significantly increased by IF it-
self and after LPS treatment in the presence or absence of
IF. To verify the DNA-binding activity of NF-κB, EMSA
was performed with nuclear proteins isolated from rat
hippocampus. Results showed that the binding activity of
NF-κB was increased by LPS treatment and also by IF and
IF + LPS treatment (Figure 3B). However, NF-κB activa-
tion and RELA translocation induced by LPS in both
groups (LPS and IF + LPS) were similar and they were also
higher than the IF group, suggesting a different pattern of
response. Interestingly, hippocampal nuclear extracts of all
groups analyzed exhibited a similar pattern of four DNA/
protein complexes (Figure 3C, D and E). The upper com-
plexes 1 and 2 were displaced by an excess of unlabeled
NF-κB, but not TFIID double-stranded oligonucleotide
consensus sequence, demonstrating the specificity of NF-
κB/DNA binding interaction (Figure 3C, D and E). The
lower complexes were less efficiently displaced by un-
labeled NF-κB probe. Supershift analysis indicated that the
antibody against the subunit RELA was able to shift DNA/
protein interaction present in complex 1. The antibody
against the subunit p50 shifted complex 2 and induced
a partial decrease in complex 1 (Figure 3C, D and E).
The presence of antibodies against the subunits cREL
(Figure 3C, D and E) and p52 (data not shown) did not
affect DNA-protein complexes. Taken together, these re-
sults indicated that p50/RELA heterodimers and p50/p50
homodimers were included in 32P-NF-κB/protein com-
plexes 1 and 2, respectively. Complexes 3 and 4 were not
displaced by the antibodies and were not considered re-
lated to NF-κB family.
Intermittent fasting reduces levels of hippocampal Tlr-4
and iNos mRNAs
Because TLR4 and iNOS mediate adverse effects of
systemic inflammation/LPS on hippocampal plasticity
[18,42,43], we measured levels of mRNAs encoding TLR4
and iNOS in hippocampal samples from rats in the four
groups. After normalization with the housekeeping Hprt
mRNA levels, the expression levels were presented as a
relative fold change compared with the Control group.
The Tlr-4 mRNA levels were significantly lower in hippo-
campi of rats in the IF and IF + LPS groups compared to
the Control group (Figure 4A). Tlr-4 mRNA levels were
also significantly lower in the IF + LPS group compared to
the LPS group (Figure 4A). Levels of iNos mRNA in-
creased sharply after LPS injection with or without IF, by
9.95-fold and 6.60-fold respectively. The iNos mRNA
levels were significantly lower in the IF + LPS group com-
pared to the LPS group (Figure 4B).
IF suppresses LPS-induced accumulation of inflammatory
proteins in the hippocampus
In view of the important role played by cytokines and che-
mokines in LPS-induced neuroinflammation [23,24,26,44],
we investigated the levels of several pro-inflammatory
cytokines and chemokines (IL-1α, IL-1β, TNF-α, IL-6,
IFN-γ, and RANTES) and the anti-inflammatory cytokine
IL-10 in the periphery (serum) and in the hippocampus, a
brain region in which neuroinflammation occurs in re-
sponse to brain injury and systemic inflammation [45,46].
Multiplex and ELISA immunoassay showed that LPS
caused a significant increase of IL-1α (Figure 5A), IL-1β
(Figure 5B), and TNF-α (Figure 5C) in the hippocampus,
and IL-1β (Figure 5 F), TNF-α (Figure 5G), IL-6 (Figure 5H),
RANTES (Figure 5I), and IFN-γ (Figure 5 J) in the serum.
Remarkably, IF significantly attenuated or completely
prevented the LPS-induced increases in all of the pro-
inflammatory cytokines in hippocampus and serum
(Figure 5). In addition, levels of RANTES were significantly
lower (Figure 5E) and levels of the anti-inflammatory cyto-
kine IL-10 were significantly elevated (Figure 5D) in the
hippocampi of rats in the IF and IF + LPS groups com-
pared to the Control and LPS groups.
IF prevents LPS-induced reduction of hippocampal BDNF
levels
BDNF plays an important role in memory and neuropro-
tection [47]. In our model, we found by ELISA immuno-
assay that LPS treatment significantly reduced hippocampal
BDNF levels when compared to all other groups (Figure 6).
This was not observed in the IF + LPS group (Figure 6),
suggesting that IF can prevent the reduction of hippocam-
pal BDNF levels caused by systemic inflammation.
Discussion
A wide array of health benefits of IF have been identified
in animal models and human studies [48]. In contrast,
no studies evaluating the effect of IF in neuroinflamma-
tory processes induced by LPS administration have been
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conducted to date. Based on studies showing that IF can
protect neurons against degeneration in animal models
of injury that involve local inflammatory processes
(stroke and seizures) and an AD model [31,32,34], and
evidence that sepsis can cause cognitive impairment in
human subjects [49], we asked whether IF might modify
the adverse effects of systemic inflammation on cogni-
tive function. Using LPS to elicit an immune response,
we observed significant impairment of memory perform-
ance in Barnes maze and inhibitory avoidance tests that
was counteracted by IF.
The Barnes circular platform was chosen as a spatial
memory paradigm [50]. This task is less stressful than
the water maze [51] and is based on the natural ten-
dency of mice to explore and escape through holes
[52,53]. We observed that, despite all groups having
learned the burrow location across successive days, there
was a significant effect of IF in improving the perform-
ance of LPS-treated rats compared to LPS-treated rats
on the Control ad libitum diet. The step-through inhibi-
tory avoidance test is based on the natural dark-seeking
behavior of rats and evaluates long-term, declarative
memory. It is a fear-motivated task in which the rat re-
frains from stepping through a door to an apparently
safer dark compartment previously linked to a punish-
ment [54,55]. Our results showed that animals treated
with LPS without IF did not remember the aversive
stimulus (foot-shock), unlike the animals previously sub-
jected to IF. The similar motor performance exhibited
by all groups (Control, IF, LPS and IF + LPS) during the
learning phase in Barnes and inhibitory avoidance be-
havioral assays as well as results from electronic motor
activity meter and rotarod apparatus confirmed that the
IF effect against LPS-induced memory impairment is
not linked to changes in general activity or motor
performance differences. Therefore, data here showed
that IF effectively prevented the memory deficit induced
by systemic inflammatory bacterial LPS administration,
suggesting a potential application of such diets to those
with or at risk for cognitive impairment.
Cognitive decline is prominent in AD, and also occurs
in other disorders in which neuroinflammation is believed
to play a prominent role [44]. Thus, the next step was to
evaluate the effects of IF on neuroinflammatory processes
induced by LPS administration. Confirming our previous
results [35,56], LPS activates nuclear RELA translocation
and NF-κB binding activity increasing pro-inflammatory
genes within two hours in rat hippocampus. Although IF
also induced an increase in NF-κB activation and nuclear
RELA translocation, the LPS response in the presence or
absence of IF was higher when compared to the IF group.
Based on the evidence that NF-κB nuclear extracts of all
groups analyzed presented a similar pattern of four DNA/
protein complexes, we consider that IF induced different
changes in the expression of NF-κB target genes involved
in synaptic plasticity and cell survival linked to a cell spe-
cific NF-κB activation when compared to LPS, since IF is
mediating a shift in LPS-induced pro-inflammatory gene
expression towards an anti-inflammatory signaling cas-
cade. In fact, there is evidence supporting a dual role of
NF-κB in neurodegenerative diseases in the central ner-
vous system (CNS); activation of NF-κB in neurons pro-
motes their survival, whereas activation in glial and
immune cells mediates pathological inflammatory pro-
cesses [16]. Confirming this hypothesis, we found that
levels of multiple markers of neuroinflammation induced
by LPS via NF-κB activation were reduced in rats on the
IF diet compared to those on the Control diet, including
iNOS, pro-inflammatory cytokines, and the LPS receptor
TLR4. In addition, our previous results showed that the
Figure 4 Intermittent fasting reduces toll-like receptor 4 (TLR4) and attenuates lipopolysaccharide (LPS)-induced synthase (iNOS)
up-regulation in the hippocampus. (A) Levels of Tlr-4 mRNA (*P = 0.008 versus Control; **P = 0.004 versus Control; #P = 0.016 versus LPS).
(B) Levels of iNos mRNA (**P = 0.015 versus Control; *P = 0.013 versus Control; #P = 0.045 versus LPS). The mRNA levels were measured by
quantitative RT-PCR in samples from hippocampus. N = 5 for each experimental group.
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Figure 5 (See legend on next page.)
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chronic unpredictable stress (CUS) protocol also induced
an increase in NF-κB activation and nuclear RELA trans-
location, but different from IF, CUS augmented the effects
of LPS on NF-κB activation and nuclear RELA transloca-
tion in hippocampus, as well as the effects of LPS on ex-
pression of the pro-inflammatory genes [56]. Therefore,
while CUS-induced sensitization of microglia reactivity
(‘priming’ stress effects) enhances inflammation [57], IF is
probably acting by engaging an adaptive cellular stress-
response signaling pathways in neurons, thus decreasing
LPS response [58].
TLR4 is expressed in astrocytes, microglia and neurons
wherein its activation can adversely affect neuronal plas-
ticity and survival in brain injury settings [21,59]. In
addition, TLR4 signaling inhibits neurogenesis [60], which
may contribute to the impairment of cognitive function by
neuroinflammation. Here, we showed that IF inhibited
LPS-induced production of pro-inflammatory mediators
including TNF-α, IL-1β, IL-6, IL-1β, RANTES, and iNos.
These effects of IF are indicative of decreased activation
of inflammatory cascades linked to NF-κB mediating pro-
inflammatory response [14,61]. In fact, it is known that
high concentrations of NO, unlike low concentrations
[42,43], may promote excitotoxicity, which may contribute
to cognitive impairment [43,62-64]. Our results showed
that IF was able to mitigate the induction of iNos expres-
sion by LPS. This result may indicate that the improved
memory performance observed in the IF + LPS group
may be related to a reduction of hippocampal iNos and
consequently the pathological levels of NO, which could
generate a cognitive deficit.
We also found that IF increases levels of IL-10, a cyto-
kine that is known to counteract NF-κB pro-inflammatory
signaling. The pro-inflammatory cytokine TNF-α plays a
central role in the onset and maintenance of inflammation
[65], while IL-10 is a prototypical anti-inflammatory cyto-
kine in that it inhibits production of inflammatory cyto-
kines and chemokines such as IL-1β, IL-6, TNF-α, IFN-γ
and RANTES [66,67]. IL-10 also acts as a natural anta-
gonist of TNF-α by inhibiting the NF-κB inflammatory
signaling through the preservation of the inhibitory pro-
tein IκB [68]. Therefore, IF simultaneously suppresses
pro-inflammatory signaling pathways and activates at least
one anti-inflammatory pathway.
Neuroinflammatory conditions such as traumatic brain
injury, AD, Down syndrome and aging are frequently asso-
ciated with cognitive impairment [69-71], and there is
considerable evidence for an association between cytokine
expression in the brain and cognitive deficits, including
memory deficits [72-74]. For instance, it has been shown
that TNF-α and IL-6 are critical for neuroinflammation-
induced memory impairment [75-77]. Also, it is well
defined that acute inflammation induced by LPS or IL-1β
injection causes memory deficits [28,78-82]. Accordingly,
it was previously shown that hippocampal IL-1β overex-
pression impairs contextual and spatial long-term memory
[74], while IL-10 inhibits LPS-induced sickness behavior
and tribulations in hippocampal-dependent memory [73].
Previous studies have shown that caloric restriction and
IF reduce levels of circulating pro-inflammatory IL-1β and
TNF-α, and increase anti-inflammatory IL-10 levels in
animal models and human subjects [83-85]. In the brain,
IL-10 may inhibit the development and progression of
chronic neurodegenerative diseases. For example, the on-
set of neuroinflammation and progression of prion disease
was accelerated in mice deficient in IL-10 [86]. In the
present study, IF exerted an anti-inflammatory effect by
increasing hippocampal IL-10 levels, and by preventing
LPS-induced increases in IL-1α, IL-1β, TNF-α, and
RANTES levels. IF also inhibited LPS-induced increases
in serum TNF-α, IL-6, RANTES and IFN-γ, suggesting
that IF anti-inflammatory effect is not restricted to the
CNS.
Finally, our findings suggest that IF can sustain neuro-
trophic support for hippocampal neurons in the setting of
systemic inflammation. The hippocampus has been dem-
onstrated to be a major brain structure involved in spatial
(See figure on previous page.)
Figure 5 Intermittent fasting (IF) inhibits lipopolysaccharide LPS)-induced increases in inflammatory mediators in the hippocampus
and serum. Levels of hippocampal IL-1α (A), IL-1β (B), TNF-α (C), IL-10 (D) and RANTES (E), and levels of serum IL-1β (F), TNF-α (G), IL-6
(H), RANTES (I) and IFN-γ (J) were measured by multiplex or ELISA (*P < 0.05 versus Control; **P < 0.01 versus Control; ***P < 0.001 versus Control;
#P < 0.05 versus LPS; ##P < 0.01 versus LPS and ###P < 0.001 versus LPS. N = 5 to 10 for each experimental group.
Figure 6 Intermittent fasting (IF) prevents lipopolysaccharide
(LPS)-induced depletion of hippocampal brain-derived
neurotrophic factor (BDNF). Levels of BDNF were measured in
hippocampal extracts by ELISA (*P < 0.05 versus Control, IF, and
IF + LPS groups. N = 10 for each experimental group.
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learning [87]. It was previously demonstrated that LPS re-
duces hippocampal mRNA levels of BDNF, a neurotrophin
that plays an important role in learning and memory pro-
cesses [88]. Accordingly, we found that LPS administration
caused a reduction in BDNF levels in the hippocampus of
rats on the Control diet, but not in rats on the IF diet.
Thus, in addition to suppressing the local (hippocampal)
and systemic inflammatory responses to LPS, IF prevented
the reduction of BDNF levels in this animal model of sys-
temic inflammation. Because BDNF plays critical roles in
hippocampal synaptic plasticity and cognitive function, it
is likely that maintenance of BDNF signaling contributes
to the beneficial effects of IF on cognitive function in LPS-
treated rats. Previous studies have provided evidence that
BDNF is a key target of NF-κB involved in NMDA
receptor-mediated cell survival signaling [89-92] and IF
has been shown to activate glutamate signaling cascade in
the CNS [58]. The ability of IF to suppress inflammatory
processes and sustain hippocampal BDNF levels in the face
of systemic inflammation, suggests that IF interventions
should be evaluated in studies of human subjects at risk
for or suffering from neurological conditions involving
neuroinflammation.
Interleukin - (IL)-1α, Interferon - (IFN)-γ, Non-Steroidal
Anti-Inflammatory Drugs –NSAIDs, Tumor Necrosis
Factor -(TNF), Nuclear factor-κB - (NF-κB), Interleukin
(IL)-1β, Brain-Derived Neurotrophic Factor – (BDNF)
inducicble nitric oxide synthase (iNOS).
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